Conference item
A meta-analysis of two randomized, double-blind, placebo-controlled, phase III studies in patients (PTS) with metastatic colorectal cancer (MCRC) receiving FOLFOX4 and PTK/ZK to determine clinical benefit on progression-free survival (PFS) in high LDH PTS
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Volume:
- 17
- Pages:
- 122-122
- Host title:
- ANNALS OF ONCOLOGY
- Publication date:
- 2006-01-01
- ISSN:
-
0923-7534
- Source identifiers:
-
346464
Item Description
- Pubs id:
-
pubs:346464
- UUID:
-
uuid:57dfb72e-7fe9-49a2-87ff-040cd16b386e
- Local pid:
- pubs:346464
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2006
If you are the owner of this record, you can report an update to it here: Report update to this record